<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Colorado Clinical and Translational Sciences Institute (CCTSI) In the News

The Colorado Sun

How doctors in Denver helped pioneer research on a new drug for food allergies

news outletThe Colorado Sun
Publish DateMarch 28, 2024

Researchers at National Jewish Health conducted some of the earliest studies on using anti-IgE drugs to prevent severe allergic reactions to food 

Full Story

Ozempic reduces severity of liver disease in people with HIV, study shows

news outletReuters
Publish DateMarch 05, 2024

The study was conducted at the CCTSI's Clinical Translational Research Center. 

Full Story
Health Affairs

For Some Patients, Better Health Starts With Finding A Home

news outletHealth Affairs
Publish DateFebruary 29, 2024

CCTSI's pilot awardee's project helps launch Denver program that links care, services and housing. 

Full Story
The Conversation

Recognizing when someone is having a seizure – and how you can help during those first critical moments

news outletThe Conversation
Publish DateFebruary 21, 2024

The Conversation US asked Dr. Jacob Pellinen, a neurologist specializing in epilepsy, to walk us through how to recognize a seizure in a bystander or loved one and what to do in those crucial moments after a seizure begins. Research is supported by the Colorado Clinical and Translational Sciences Institute.

Full Story
Daily Camera

CU Boulder center supports human biomedical research

news outletDaily Camera
Publish DateNovember 23, 2023

Chris DeSouza, who leads the Clinical Translational Research Center at CU Boulder, said the center is the only one housed in an undergraduate non-medical campus nationwide. It’s supporting more than a dozen active research protocols at CU Boulder.

Full Story
CU Connections

Five questions for Ron Sokol and Janine Higgins

news outletCU Connections
Publish DateNovember 16, 2023

Leaders of CCTSI on how $54 million grant will help power innovation, health equity.

Full Story
Denver Gazette

National Institutes of Health awards $54 million to CU Anschutz

news outletDenver Gazette
Publish DateOctober 13, 2023

The funding, to be awarded over a seven-year period, is the fourth consecutive time the federal agency has funded the Colorado Clinical and Translational Sciences Institute located on the CU Anschutz campus in Aurora since 2008.

Full Story
Colorado Public Radio

Do you have long COVID? This Colorado research is trying to help identify just what it does and what to do about it

news outletColorado Public Radio
Publish DateSeptember 21, 2023

The outpatient clinics of the Colorado Clinical and Translational Sciences Institute (CCTSI) on the CU Anschutz campus was one of the sites where researchers worked.

Full Story

Researchers are testing treatments for long COVID symptoms, ranging from brain fog to shortness of breath

news outletUCHealth
Publish DateSeptember 12, 2023

The studies, which are part of the RECOVER initiative, target a host of symptoms that are most troubling for patients enduring long-term health effects after COVID-19.

Full Story
Alamosa News

Colorado Trust appoints Coleman and Nease as 2024 trustees

news outletAlamosa News
Publish DateJuly 14, 2023

“I am absolutely thrilled to have Mayor Coleman and Dr. Nease joining us as trustees,” said the Rev. Louise Westfall, 2023 board chair of The Colorado Trust.

Full Story
US News

Paxlovid Remains Potent Against Omicron COVID Cases

news outletUS News
Publish DateMarch 14, 2023

"We are really struggling with maintaining effective therapeutic options for high-risk patients with COVID-19," said Dr. Adit Ginde.

Full Story
Alamosa News

SLV groups look to help fight scarcity of childcare

news outletAlamosa News
Publish DateDecember 12, 2022

CCTSI Community Research Liaison gathers 80 San Louis Valley organizations to help fight scarcity of childcare.

Full Story

CU Anschutz launches new program aimed at involving older adults in clinical trials

news outlet9News
Publish DateDecember 08, 2022

The Colorado Clinical and Translational Sciences Institute has been putting a focus on recruiting diverse participants in clinical research—the OARS program is key to this effort.

Full Story

Inside Colorado’s Battle Against Rare Diseases

news outlet5280
Publish DateAugust 03, 2022

Melissa Haendel’s background in genetic research might be the key to coordinating rare disease information across the CU Anschutz Campus—and the world. Haendel is one of the leaders in the Colorado Clinical and Translational Sciences Institute (CCTSI).

Full Story

Q&A: Nationwide long COVID-19 study needs more participants

news outlet9News
Publish DateAugust 03, 2022

A CCTSI study looking at the long-term side effects some patients are facing months after a positive COVID-19 test, a condition often called long COVID, is searching for more participants.

Full Story

Prescription exercise?

news outletToday
Publish DateJune 06, 2022

In our new series Beyond the Scale, NBC’s John Torres reports for TODAY on a groundbreaking study at the National Institutes of Health that could help doctors prescribe personalized workout plans for patients.

Full Story

More than half of early Covid-19 patients at one hospital had symptoms two years later, study finds

news outletCNN
Publish DateMay 11, 2022

Even two years after their initial infection, the majority of people who were hospitalized with Covid-19 early in the pandemic had lingering symptoms, according to a new study that may be one of the longest and largest on record to follow people with long Covid.

Full Story

CU Anschutz exhibit highlights disparities in care for LGBTQ elders

news outlet9News
Publish DateMay 01, 2022

Carey Candrian, a member of the CCTSI PACT Council, received multiple grants to work on the project titled Eye to Eye, which is on display at the Fulginiti Pavilion for Bioethics and Humanities on the CU Anschutz campus.

Full Story

Researchers test the power of machine learning to unravel long Covid’s mysteries

news outletSTAT
Publish DateApril 29, 2022

Long Covid, with its constellation of symptoms, is proving a challenging moving target for researchers trying to conduct large studies of the syndrome. As they take aim, they’re debating how to responsibly use growing piles of real-world data — drawing from the full experiences of long Covid patients, not just their participation in stewarded clinical trials.

Full Story
Technology Networks

Adjusting Diet To Prevent Breast Cancer Recurrence

news outletTechnology Networks
Publish DateFebruary 10, 2022

A collaboration between the CU Cancer Center, the Anschutz Health and Wellness Center, the Colorado NORC, and the Colorado Clinical and Translational Sciences Institute, the study will look not just at how losing weight might help breast cancer survivors prevent relapse, but if certain dietary weight-loss strategies have additional benefits when it comes to the disease.

Full Story

Monoclonal antibody treatment part of state's effort to fight COVID-19

news outlet9News
Publish DateNovember 14, 2021

This type of treatment is part of the latest push from the state to keep COVID-19 patients out of the hospital.

Full Story
The Colorado Sun

The story of the historic COVID vaccine trial for kids at Children’s Hospital Colorado

news outletThe Colorado Sun
Publish DateOctober 18, 2021

An elementary school boy came to every appointment in a kid-sized lab coat, a children’s book about mRNA vaccines in his arms. Another child announced she was “helping science.” And Kaniya Smith told her friends in the fourth grade that she was taking the coronavirus vaccine to test it out for the rest of them. 

Full Story
Medical Xpress

New study reveals serious long-term complications in youth-onset type 2 diabetes

news outletMedical Xpress
Publish DateJuly 21, 2021

Phil Zeitler, MD, Ph.D., has been treating youth with type 2 diabetes for more than 20 years. He and a team of researchers published a paper today on the TODAY2 study in the New England Journal of Medicine on the long-term complications of type 2 diabetes. (TODAY stands for Treatment Options for type 2 Diabetes in Adolescents and Youth. The first phase of the study took place from 2004—2011; phase two from 2011—2020. Both studies involved more than 550 participants from across the country.)

Full Story

New study determines cystic fibrosis therapy is safe and effective for young children

news outletScienMag
Publish DateMay 07, 2021

Children ages two to five who have the most common form of cystic fibrosis (CF), caused by two copies of the F508 gene mutation, have not had any modulator treatments available to them until recently. A new study authored by researchers at Children’s Hospital Colorado and published May 6, 2021, in Lancet Respiratory Medicine shows that the CFTR modulator – lumacaftor/ivacaftor – can be safe and well-tolerated for this age range for up to 120 weeks, allowing younger children to begin proactive treatment of CF earlier in their lives.

Full Story
Fox 31 | Channel 2

More Coloradans should take advantage of COVID-19 treatment

news outletFox 31 | Channel 2
Publish DateApril 14, 2021

DENVER (KDVR) — As many focus on the race to get Coloradans vaccinated against COVID-19, doctors and scientists continue to work to improve treatments for those who contract the virus. Monoclonal Antibody treatment first gained attention last fall as the U.S. Food and Drug Administration issued emergency use authorization to use it to treat mild to moderate cases of COVID-19 in adults. The treatment is more widely available now, according to Dr. Adit Ginde, a University of Colorado School of Medicine faculty member.

Full Story

Colorado Clinical and Translational Sciences Institute (CCTSI) News Topics